Medical Device Success

JANUARY 15, 2020

Start your 2020 New Year’s Revolution today. The post 2020 Medtech Resolutions? Another way to network is to start a like-minded group in your local area via community building platform like Meet Up ( [link] ). It is never too late. No doubt you have some good ideas as well. Please share! Make them a Revolution!

Networking 130

Networking Management Engineering Sales 130

Integrity Solutions

JANUARY 18, 2021

Now that 2020 is in the rear view mirror, most of us are ready to bid good riddance to an incredibly tumultuous year and do our best to forget it. But before you barrel ahead into 2021 and look for signs of returning to the “good old days,” sales leaders and their teams have a lot to learn from 2020.

Sales pipeline 126

Sales pipeline Sales Prospecting Sales process 126

MedCity News

SEPTEMBER 14, 2022

in 2020, the report found. Overall spending by employers and employees on mental health services as a percentage of total spending rose from 6.8% in 2013 to 8.2% The use of the mental health services also increased, especially in outpatient settings.

96

96

Fierce Pharma

APRIL 8, 2024

The FDA refused to accept Supernus' first approval bid after the company acquired the med in 2020. The third time is decidedly not the charm for Supernus and its Parkinson’s disease infusion pump. | The following year, the agency doled out a complete response letter, dashing Supernus' second try.

FDA 274

FDA 274

Integrity Solutions

FEBRUARY 12, 2020

Many sales influencers are doing great things, but we wanted to shine a spotlight on a few of our favorites, those whose viewpoints align well with ours and can help motivate you and your teams to perform better in 2020. . The post Our 10 (OK, 11) Favorite Sales Influencers of 2020 appeared first on Integrity Solutions.

Sales 124

Sales B2B Sales Sales Strategy Prospecting 124

Integrity Solutions

MAY 12, 2020

Sales Enablement Strategy: 2020 vs. 2019. The post Adapting Your Sales Enablement Strategy to 2020 Realities appeared first on Integrity Solutions. So then what should sales enablement strategy mean, particularly now, and how can it help your sales team deal with the specific challenges of this current selling environment?

Sales 126

Sales Sales Management Management Training 126

Pharma Marketing Network

APRIL 27, 2021

HBA STAR 2020-21, Susan Torroella. The 2020-2021 HBA STAR is Susan Torroella, President and CEO of ArmadaHealth, the leader in physician recommendation intelligence provided to employers through its QualityCare Connect? The post Susan Torroella, 2020-2021 HBA STAR appeared first on Pharma Marketing Network.

Physicians 52

Physicians Networking Pharma Healthcare 52

Sales Talent

FEBRUARY 7, 2020

By comparing these forecasts to historical data, we developed our 2020 sales hiring forecast. 2020 Sales Hiring Forecast. Sales hiring in 2020 shows no signs of slowing down. Manpower forecasts a Q1 2020 Net Employment Outlook for the U.S. 4 percent in 2020. 2019 Sales Hiring in Review. YOY increase.

Sales 52

Sales B2B Sales Recruitment Marketing 52

Fierce Pharma

JUNE 29, 2023

After an initial rejection in 2020 and a review delay earlier this year, BioMarin’s Roctavian has finally got the FDA go-ahead to introduce a gene therapy for a not-so-rare disorder.

Doctors 340

Doctors FDA 340

Teachntest

JANUARY 11, 2022

D Pharmacy First Year Notes and MCQ with Answers ER 2020 As per the new syllabus of D Pharmacy ER 2020 If you’re pursuing a Diploma in Pharmacy (D.Pharm), you know that taking notes is an essential part of your studies. As a first-year student, it’s important to have access to comprehensive notes that cover. Read more

Pharmaceutical 52

Pharmaceutical Pharma 52

MobileLocker

DECEMBER 3, 2020

Check out all the marketing and communications trends from 2020 and learn how they could impact the year ahead. The post Pharma and Med Tech Marketing: 2020 in Review appeared first on MobileLocker.

Marketing 52

Marketing Pharma Healthcare Healthcare 52

Pharmaceutical Technology

DECEMBER 16, 2022

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% The figure below summarises the endometriosis market growth across the 7MM from 2020 to 2030. At the end of 2030, the US will contribute approximately 81.3% of 7MM sales.

Marketing 59

Marketing Side effects Sales Safety 59

Pharma Marketing Network

NOVEMBER 12, 2020

Healthcare Internet Conference ( HCIC) | November 16-19, 2020 | VIRTUAL. For 2020, we are excited to present HCIC@Home – a virtual conference featuring the same type of content you’ve been accustomed to at our annual in-person conference. Register now!

Healthcare 52

Healthcare Healthcare CRM Networking 52

Pharma Marketing Network

NOVEMBER 11, 2020

Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. Pharma Marketing 2020: The Enduring Impact .

Marketing 52

Marketing Pharma Competition Doctors 52

Fierce Pharma

DECEMBER 20, 2023

In 2020, Palatin Technologies paid $12 million to regain the rights in North America to its struggling female libido drug Vyleesi. | In 2020, Palatin paid $12 million to regain the rights in North America to its struggling female libido drug Vyleesi.

Medicine 217

Medicine Marketing 217

Pharma Marketing Network

SEPTEMBER 16, 2020

PanAgora Pharma: Pharma Action in Patient Advocacy Summit | December 2020. The Pharma Action in Patient Advocacy Summit 2020 will bring together 200+ customer experience leaders, patient advocates, advocacy groups, and pharma patient advocacy leaders to learn how pharma can work with patients to deliver more compelling experiences.

Pharma 52

Pharma Patients Networking Marketing 52

Fierce Pharma

DECEMBER 8, 2023

Elizabeth Mily, who replaced BMS’ former M&A czar Paul Biondi back in 2020, is headed for the exit, the company confirmed Friday. Three years on, Bristol Myers Squibb is bidding adieu to its top dealmaker. Three years on, Bristol Myers Squibb is bidding adieu to its top dealmaker.

305

305

Integrity Solutions

DECEMBER 21, 2020

For most of us, 2020 is a year we’ll be glad to see in the rear-view mirror. While disruption is always rough when you’re going through it, as 2020 closes out, we can also reflect back on some of the silver linings and positive developments that came out of the year.

Training 69

Training Sales Ethics Consulting 69

Pharma Marketing Network

SEPTEMBER 16, 2020

Reuters Events: Pharma Awards USA 2020 VIRTUAL |. Now, in a completely virtual form, The Reuters Events: Pharma Awards USA 2020 exist as the only pharma awards to elevate and showcase the very best work from across the industry to a global audience – on a virtual stage. 7-9 December. Sponsored by Reuters Events Pharma.

Pharma 52

Pharma Networking Patients Marketing 52

Pharma Marketing Network

OCTOBER 28, 2020

Re: Imagine Pharma Marketing | November 9-11 | 2020 VIRTUAL EVENT. The post Re: Imagine Pharma Marketing, November 9-11, 2020 VIRTUAL EVENT appeared first on Pharma Marketing Network. How can we as a community decide what will be the true drivers of value moving forward in our strategic/commercial roadmaps? Register today here!

Marketing 52

Marketing Pharma Networking 52

CLD, Inc.

DECEMBER 30, 2020

As 2020 wraps up, let’s take a bit of time to reflect on some of the ways sales training has changed this year.

Training 52

Training Sales 52

Pharma Marketing Network

APRIL 27, 2021

HBA Honorable Mentor 2020-21, Dr. Rod MacKenzie. The post Dr. Rod MacKenzie, 2020-2021 HBA Honorable Mentor appeared first on Pharma Marketing Network. Rod MacKenzie, PhD, is Chief Development Officer and Executive Vice President for Pfizer.

Medicine 52

Medicine Networking Safety Marketing 52

Fierce Pharma

DECEMBER 8, 2023

It’s also the first medicine using the revolutionary CRISPR gene-editing system, which earned its inventors a Nobel Prize in 2020 and holds tantalizing potential to cure diseases for which there is no treatment.

FDA 322

FDA Medicine Pharmaceutical 322

Pharma Marketing Network

SEPTEMBER 16, 2020

PanAgora Pharma: 3rd Annual Pharma CX Tech Summit | November 12, 2020. The post PanAgora Pharma: </br>3rd Annual Pharma CX Tech Summit </br>November 12, 2020 appeared first on Pharma Marketing Network. Sponsored by PanAgora Pharma.

Pharma 52

Pharma Networking Pharmaceutical Marketing 52

Tribeca Knowledge

NOVEMBER 17, 2020

A ny fears that COVID-19 might stem the flow of new drug approvals in 2020, depleting or diverting resources at regulatory agencies and their pharmaceutical clients, appear largely premature.

Marketing 52

Marketing FDA Pharmaceutical Pharma 52

Pharma Marketing Network

APRIL 20, 2021

The post Dr. Sandra Horning, HBA Woman of the Year 2020-21 appeared first on Pharma Marketing Network. Given her commitment to helping others, she has also been cited as an exceptional mentor, coaching and inspiring hundreds of female and male scientists and healthcare business leaders.

Medicine 52

Medicine Education Networking Pharma 52

Fierce Pharma

FEBRUARY 6, 2024

Incyte previously bought into a Monjuvi collaboration for $750 million ahead of the drug's 2020 approval. . | While Incyte gained more rights to lymphoma med Monjuvi, Novartis claimed the rest of MorphoSys for €2.7B

191

191

Pharma Marketing Network

AUGUST 18, 2020

The obvious trigger for much of the conversations happening around HCP communication was the loss of the sales rep / field force for much of 2020 to date. The post 3 Key Takeaways: DHC Group Omnichannel Roundtable August 2020 appeared first on Pharma Marketing Network.

Physicians 59

Physicians Sales Marketing Pharma 59

Fierce Pharma

JULY 6, 2023

GSK’s Cabenuva made history in 2020 as the world’s firs | GSK's long-acting Cabenuva is currently approved only as a switch therapy for patients who already have undetectable HIV levels in the blood. Trying to reach some tough populations who have difficulty adhering to existing daily oral therapies, GSK is getting creative.

Patients 252

Patients 252

Pharma Marketing Network

APRIL 19, 2021

Tune into an exclusive Pharma Marketing Network (PMN) interview with Amy Turnquist, a member of the PMN Editorial Advisory Board and Dr. Sandra Horning, the Healthcare Businesswomen’s Association Woman of the Year (WOTY) 2020-21. Confidence and persistence come from within.” – Dr. Sandra Horning, HBA Woman of the Year 2020-21.

Networking 40

Networking Specialization Education Pharma 40

Fierce Pharma

OCTOBER 24, 2023

Under a 2020 collaboration with MyoKardia, LianBio has held Asian rights to the potential blockbuster cardio drug mavacamten. LianBio originally held the med's Asia commercialization rights under a 2020 collaboration with MyoKardia, which was later bought by Bristol Myers. Now, BMS is ponying up for those rights.

133

133

Rep-Lite

JANUARY 27, 2021

Rep-Lite has been recognized as the “Most Pioneering Hybrid Medical Contract Sales & Services Enterprise 2020” by GHP magazine in its fifth annual Healthcare & Pharmaceutical Awards. GHP ’s award [Most Pioneering Hybrid Medical Contract Sales & Services Enterprise 2020] is a perfect title for what we do.

Medical 52

Medical Sales Medical sales Healthcare 52

Fierce Pharma

JUNE 30, 2023

The Securities and Exchange Commission (SEC) has revealed insider trading charges against five—including former Alexion Vice President | The SEC has revealed insider trading charges against five—including former Alexion vice president Joseph Dupont and a Massachusetts police chief—who allegedly took advantage of prior knowledge of Alexion’s 2020 acquisition (..)

Pharmaceutical 231

Pharmaceutical 231

Pharma Marketing Network

SEPTEMBER 1, 2020

Contact eHealthcare Solutions to learn more about their new video offering coming October 1, 2020. It is forecasted that more than one in five total U.S. advertising dollars will go to digital video placements.

Media 52

Media 52

Fierce Pharma

AUGUST 3, 2023

Back in 2020, a surprise manufacturing shortfall led to an import ban of Bristol Myers Squibb’s Abraxane, sold by BeiGene, in China. Back in 2020, a surprise manufacturing shortfall led to an import ban of Bristol Myers Squibb’s Abraxane, sold by BeiGene, in China.

Manufacturing 130

Manufacturing 130

Fierce Pharma

JULY 13, 2023

billion in 2020 to a projec | A phase 3 study has shown that a new, subcutaneous version of Roche's Ocrevus has proven to be non-inferior to the current infused treatment as measured by the level of drug in the blood, 12 weeks after administration. With the multiple sclerosis market growing rapidly—from $18.9

Marketing 233

Marketing Patients 233